| Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats M Mejias, E Garcia‐Pras, C Tiani, R Miquel, J Bosch, M Fernandez Hepatology 49 (4), 1245-1256, 2009 | 392 | 2009 |
| Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet‐derived growth factor blockade in rats M Fernandez, M Mejias, E Garcia‐Pras, R Mendez, JC Garcia‐Pagan, ... Hepatology 46 (4), 1208-1217, 2007 | 247 | 2007 |
| Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension M Mejias, E Garcia-Pras, J Gallego, R Mendez, J Bosch, M Fernandez Journal of hepatology 52 (4), 529-539, 2010 | 147 | 2010 |
| Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension C Tiani, E Garcia-Pras, M Mejias, A De Gottardi, A Berzigotti, J Bosch, ... Journal of hepatology 50 (2), 296-305, 2009 | 107 | 2009 |
| Sequential functions of CPEB1 and CPEB4 regulate pathologic expression of vascular endothelial growth factor and angiogenesis in chronic liver disease V Calderone, J Gallego, G Fernandez-Miranda, E Garcia-Pras, C Maillo, ... Gastroenterology 150 (4), 982-997. e30, 2016 | 77 | 2016 |
| Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients M García-López, S Lens, LJ Pallett, B Testoni, S Rodríguez-Tajes, ... Journal of hepatology 74 (5), 1064-1074, 2021 | 74 | 2021 |
| Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats M Mejias, L Coch, A Berzigotti, E Garcia-Pras, J Gallego, J Bosch, ... Gut 64 (4), 657-666, 2015 | 59 | 2015 |
| The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats M Mejias, E Garcia‐Pras, C Tiani, J Bosch, M Fernandez Journal of cellular and molecular medicine 12 (5a), 1690-1699, 2008 | 53 | 2008 |
| Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats M D'Amico, M Mejías, E García-Pras, JG Abraldes, JC Garcia-Pagan, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 302 (10 …, 2012 | 52 | 2012 |
| Disruption of negative feedback loop between vasohibin‐1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats L Coch, M Mejias, A Berzigotti, E Garcia‐Pras, J Gallego, J Bosch, ... Hepatology 60 (2), 633-647, 2014 | 46 | 2014 |
| Cell death in hepatocellular carcinoma: pathogenesis and therapeutic opportunities E García-Pras, A Fernández-Iglesias, J Gracia-Sancho, ... Cancers 14 (1), 48, 2021 | 38 | 2021 |
| Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling M Coll, S Ariño, C Martínez‐Sánchez, E Garcia‐Pras, J Gallego, A Moles, ... Hepatology 75 (2), 353-368, 2022 | 26 | 2022 |
| Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension E Garcia-Pras, J Gallego, L Coch, M Mejias, G Fernandez-Miranda, ... Gut 66 (7), 1306-1320, 2017 | 23 | 2017 |
| Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis N Pell, E Garcia-Pras, J Gallego, S Naranjo-Suarez, A Balvey, C Suñer, ... Molecular Metabolism 54, 101388, 2021 | 11 | 2021 |
| Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension J Gallego, E Garcia-Pras, M Mejias, N Pell, U Schaeper, M Fernandez Scientific Reports 7 (1), 14791, 2017 | 10 | 2017 |
| Pathogenesis of portal hypertension: extrahepatic mechanisms M Fernandez, M Mejias, E Garcia-Pras, J Gallego, N Pell, M Ramirez, ... Current Hepatology Reports 15, 199-207, 2016 | 3 | 2016 |
| The somatostatin analogue octreotide inhibits angiogenesis and VEGF expression in early, but not late, stages of portal hypertension in rats. Role of somatostatin receptor … M Mejias, E Garcia-Pras, J Bosch, M Fernandez HEPATOLOGY 46 (4), 607A-607A, 2007 | | 2007 |
